More M&As to follow Life Technologies in 2015, says Thermo Fisher
Thermo Fisher says its $15bn acquisition of Life Technologies last year created cash savings it will pump into a series of aggressive M&As.
Thermo Fisher says its $15bn acquisition of Life Technologies last year created cash savings it will pump into a series of aggressive M&As.
Cell therapy manufacturer NeoStem and contract manufacturer Invetech have agreed to develop a new closed processing system for cell therapy manufacturing.
Lonza signed a flurry of biopharma-related deals and launched a number of drug industry services in the final quarter of 2014 as its efforts to focus on pharma intensified.